A new rule implemented by the U.S. Patent and Trademark Office will limit the number of "continuing applications" to be filed for any single invention, which could require medical device makers to change their patent strategies. A patent attorney said the ruling may increase the need to prepare a prosecution strategy for each case.

Related Summaries